Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 18 studies | 35% ± 18% | |
| type I pneumocyte | 11 studies | 33% ± 14% | |
| epithelial cell | 10 studies | 37% ± 19% | |
| basal cell | 10 studies | 30% ± 12% | |
| endothelial cell | 8 studies | 20% ± 3% | |
| secretory cell | 8 studies | 26% ± 8% | |
| goblet cell | 6 studies | 21% ± 5% | |
| endothelial cell of artery | 5 studies | 21% ± 6% | |
| endothelial cell of lymphatic vessel | 5 studies | 20% ± 5% | |
| deuterosomal cell | 4 studies | 25% ± 4% | |
| squamous epithelial cell | 4 studies | 44% ± 20% | |
| type II pneumocyte | 3 studies | 31% ± 9% | |
| extravillous trophoblast | 3 studies | 42% ± 10% | |
| club cell | 3 studies | 37% ± 15% | |
| respiratory goblet cell | 3 studies | 28% ± 12% | |
| luminal cell of prostate epithelium | 3 studies | 45% ± 3% | |
| megakaryocyte | 3 studies | 29% ± 14% | |
| brush cell | 3 studies | 29% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 6001.59 | 459 / 459 | 99% | 115.50 | 1110 / 1118 |
| thymus | 100% | 10376.20 | 653 / 653 | 99% | 104.41 | 600 / 605 |
| lung | 100% | 16345.15 | 578 / 578 | 99% | 148.90 | 1142 / 1155 |
| liver | 100% | 8558.44 | 226 / 226 | 98% | 90.38 | 397 / 406 |
| pancreas | 100% | 5608.91 | 328 / 328 | 97% | 118.33 | 173 / 178 |
| prostate | 96% | 6832.64 | 236 / 245 | 99% | 56.71 | 498 / 502 |
| kidney | 100% | 7318.61 | 89 / 89 | 94% | 49.40 | 849 / 901 |
| ovary | 97% | 3315.99 | 175 / 180 | 97% | 47.37 | 417 / 430 |
| stomach | 90% | 6155.99 | 322 / 359 | 97% | 66.95 | 277 / 286 |
| bladder | 86% | 5377.71 | 18 / 21 | 99% | 149.21 | 498 / 504 |
| esophagus | 81% | 7772.82 | 1164 / 1445 | 99% | 105.15 | 181 / 183 |
| intestine | 77% | 5465.29 | 740 / 966 | 98% | 86.85 | 519 / 527 |
| uterus | 71% | 1745.38 | 121 / 170 | 90% | 151.45 | 414 / 459 |
| adrenal gland | 100% | 5809.55 | 258 / 258 | 27% | 11.36 | 61 / 230 |
| skin | 72% | 7397.84 | 1306 / 1809 | 39% | 12.85 | 185 / 472 |
| spleen | 100% | 5181.40 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 164.04 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 99.00 | 1 / 1 |
| adipose | 100% | 5000.23 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 97% | 6070.05 | 897 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 72% | 18.72 | 21 / 29 |
| heart | 68% | 1486.68 | 583 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 48% | 1065.24 | 637 / 1335 | 0% | 0 | 0 / 0 |
| brain | 20% | 406.99 | 539 / 2642 | 8% | 1.96 | 56 / 705 |
| eye | 0% | 0 | 0 / 0 | 24% | 6.02 | 19 / 80 |
| muscle | 13% | 221.86 | 102 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0072659 | Biological process | protein localization to plasma membrane |
| GO_0006954 | Biological process | inflammatory response |
| GO_0071260 | Biological process | cellular response to mechanical stimulus |
| GO_0035683 | Biological process | memory T cell extravasation |
| GO_1903142 | Biological process | positive regulation of establishment of endothelial barrier |
| GO_0051493 | Biological process | regulation of cytoskeleton organization |
| GO_1902396 | Biological process | protein localization to bicellular tight junction |
| GO_0090559 | Biological process | regulation of membrane permeability |
| GO_0031032 | Biological process | actomyosin structure organization |
| GO_0046718 | Biological process | symbiont entry into host cell |
| GO_2000810 | Biological process | regulation of bicellular tight junction assembly |
| GO_0050892 | Biological process | intestinal absorption |
| GO_0001817 | Biological process | regulation of cytokine production |
| GO_0035633 | Biological process | maintenance of blood-brain barrier |
| GO_1901731 | Biological process | positive regulation of platelet aggregation |
| GO_0090557 | Biological process | establishment of endothelial intestinal barrier |
| GO_0008360 | Biological process | regulation of cell shape |
| GO_0035025 | Biological process | positive regulation of Rho protein signal transduction |
| GO_0098609 | Biological process | cell-cell adhesion |
| GO_0032956 | Biological process | regulation of actin cytoskeleton organization |
| GO_0051497 | Biological process | negative regulation of stress fiber assembly |
| GO_0007159 | Biological process | leukocyte cell-cell adhesion |
| GO_0070160 | Cellular component | tight junction |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0032991 | Cellular component | protein-containing complex |
| GO_0005911 | Cellular component | cell-cell junction |
| GO_0005923 | Cellular component | bicellular tight junction |
| GO_0030054 | Cellular component | cell junction |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0045296 | Molecular function | cadherin binding |
| GO_0001618 | Molecular function | virus receptor activity |
| GO_0005178 | Molecular function | integrin binding |
| GO_0030165 | Molecular function | PDZ domain binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | F11R |
| Protein name | Junctional adhesion molecule A (Junctional adhesion molecule 1) Junctional adhesion molecule A (JAM-A) (Junctional adhesion molecule 1) (JAM-1) (Platelet F11 receptor) (Platelet adhesion molecule 1) (PAM-1) (CD antigen CD321) |
| Synonyms | JAM1 JCAM hCG_20857 UNQ264/PRO301 |
| Description | FUNCTION: Seems to play a role in epithelial tight junction formation. Appears early in primordial forms of cell junctions and recruits PARD3 . The association of the PARD6-PARD3 complex may prevent the interaction of PARD3 with JAM1, thereby preventing tight junction assembly (By similarity). Plays a role in regulating monocyte transmigration involved in integrity of epithelial barrier (By similarity). Ligand for integrin alpha-L/beta-2 involved in memory T-cell and neutrophil transmigration . Involved in platelet activation . .; FUNCTION: (Microbial infection) Acts as a receptor for Mammalian reovirus sigma-1. .; FUNCTION: (Microbial infection) Acts as a receptor for Human Rotavirus strain Wa. . |
| Accessions | Q9Y624 Q6FIB4 ENST00000621309.4 A0A087WY82 ENST00000537746.1 [Q9Y624-2] ENST00000368026.11 [Q9Y624-1] |